Skip to main content

GeneDx Holdings Corp.

corporate_fare Company Profile

GeneDx Holdings Corp.

WGS·NASDAQ·Industrial Applications And Services·CIK 0001818331

GeneDx Holdings Corp. provides genomic testing services. The company offers ExomeDx™ and GenomeDx™ tests, which are ranked #1 by expert geneticists and have received FDA Breakthrough Device Designation. These tests enable clinicians to provide precise, fast, and actionable diagnoses. GeneDx Holdings combines clinical expertise, advanced technology, and its proprietary GeneDx Infinity™ dataset to power these tests. The GeneDx Infinity™ dataset also supports discovery for biopharma and aims to drive the future of precision genetic medicine. GeneDx was founded in 2000 by scientists from the National Institutes of Health with the goal of making genetic testing accessible for patients with rare diseases. The company became a leader in genomics, establishing methods for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. Over 25 years, GeneDx has built one of the world's largest rare disease datasets, GeneDx Infinity™. GeneDx Holdings acquired GeneDx, LLC on April 29, 2022, and Fabric Genomics, Inc. on May 5, 2025. The company's Class A common stock and public warrants are listed on the Nasdaq Global Select Market under the symbols "WGS" and "WGSWW," respectively.

GeneDx Holdings Corp. (NASDAQ:WGS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 34 items for WGS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for WGS spans 8-K, 10-Q, 4, SCHEDULE 13D/A.

Recent high-impact activity:

  • GeneDx Confirms CEO Handoff: Cunningham In, Stueland Out by December 15
  • GeneDx Swaps CEOs: Ex-Illumina Commercial Chief Cunningham Takes Over by December 15
  • GeneDx Slides Premarket as Q4 Revenue Outlook Lands Well Below Consensus
  • GeneDx 10-Q: Q3 Net Loss Widens to $12.3M, Nine-Month Operating Cash Burn Hits $72M
  • GeneDx Q3 Revenue Up 5% but Adjusted Profit Halves; Guidance Trimmed

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$427.54M
Net Income
-$21.02M
Diluted EPS
-$0.73
Op. Cash Flow
$33.28M
Free Cash Flow
$14.26M
Gross Profit
$298.17M
Operating Income
-$13.08M
Cash & Equivalents
$105M
Total Debt
$52.72M
Debt / Equity
0.17×
Net Margin
-4.9%
Shares Outstanding
29.25M sh
Source: 10-K · filed 2026-02-23 · accession 0001818331-26-000015

Short Interest & Short Volume

7.27 days to cover

FINRA reported short interest of 6,552,860 shares in WGS as of the October 30, 2026 settlement, a 8.8% increase from the prior period — about 7.3 days to cover at its recent average daily volume. On November 20, 2026, 64.9% of WGS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)6,552,860 shares as of October 30, 2026
Change vs prior period▲ 8.8%
Days to cover7.27 at avg daily volume of 901,145
Daily short volume (FINRA facilities)64.9% of 287,959 shares on November 20, 2026
5-day average short volume70.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with W →
$46.35 +1.96% today
52-week range · as of 2026-11-18 $32.21 – $170.87
Market cap
$1.36B
Volume
912.6K (0.8× avg)
3-mo avg 1.1M
Live data · 2026-11-21 08:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed WGS - Latest Insights

WGS
Nov 18, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $48.01
Real-time Price: $46.35 info
Change: -$1.66 (-3%) info
Market Cap: $1.363B info
WGS
Nov 18, 2026, 8:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $47.40
Real-time Price: $46.35 info
Change: -$1.05 (-2%) info
Market Cap: $1.363B info
WGS
Nov 10, 2026, 7:08 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $58.00
Real-time Price: $46.35 info
Change: -$11.65 (-20%) info
Market Cap: $1.363B info
WGS
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $46.35 info
Change: -$12.65 (-21%) info
Market Cap: $1.363B info
WGS
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $65.65
Real-time Price: $46.35 info
Change: -$19.30 (-29%) info
Market Cap: $1.363B info
WGS
Aug 03, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.01
Real-time Price: $46.35 info
Change: -$30.66 (-40%) info
Market Cap: $1.363B info
WGS
Aug 03, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $62.47
Real-time Price: $46.35 info
Change: -$16.12 (-26%) info
Market Cap: $1.363B info
WGS
Aug 03, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $60.19
Real-time Price: $46.35 info
Change: -$13.84 (-23%) info
Market Cap: $1.363B info
WGS
Jul 16, 2026, 10:09 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $65.44
Real-time Price: $46.35 info
Change: -$19.09 (-29%) info
Market Cap: $1.363B info
WGS
Jul 07, 2026, 8:46 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $65.01
Real-time Price: $46.35 info
Change: -$18.66 (-29%) info
Market Cap: $1.363B info
WGS
Jun 29, 2026, 3:24 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $69.23
Real-time Price: $46.35 info
Change: -$22.88 (-33%) info
Market Cap: $1.363B info
WGS
Jun 16, 2026, 8:39 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $61.69
Real-time Price: $46.35 info
Change: -$15.34 (-25%) info
Market Cap: $1.363B info
WGS
Jun 09, 2026, 9:32 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $53.15
Real-time Price: $46.35 info
Change: -$6.80 (-13%) info
Market Cap: $1.363B info
WGS
Jun 08, 2026, 5:25 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $51.80
Real-time Price: $46.35 info
Change: -$5.45 (-11%) info
Market Cap: $1.363B info
WGS
May 28, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $48.18
Real-time Price: $46.35 info
Change: -$1.83 (-4%) info
Market Cap: $1.363B info
WGS
May 22, 2026, 5:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $47.02
Real-time Price: $46.35 info
Change: -$0.6738 (-1%) info
Market Cap: $1.363B info
WGS
May 20, 2026, 7:45 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $44.40
Real-time Price: $46.35 info
Change: +$1.95 (+4%) info
Market Cap: $1.363B info
WGS
May 15, 2026, 7:07 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $40.38
Real-time Price: $46.35 info
Change: +$5.97 (+15%) info
Market Cap: $1.363B info
WGS
May 15, 2026, 7:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $40.38
Real-time Price: $46.35 info
Change: +$5.97 (+15%) info
Market Cap: $1.363B info
WGS
May 11, 2026, 9:21 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $39.42
Real-time Price: $46.35 info
Change: +$6.93 (+18%) info
Market Cap: $1.363B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets